Cargando…

Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Multiparametric magnetic-resonance imaging (mpMRI) is a routinely used imaging modality for diagnosing prostate cancer but misses 10–20% of prostate tumours. Recently, prostate-specific membrane antigen positron-emission tomography (PSMA PET) has been proposed as an alternative to mp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yi, Simpson, Benjamin S., Morka, Naomi, Freeman, Alex, Kirkham, Alex, Kelly, Daniel, Whitaker, Hayley C., Emberton, Mark, Norris, Joseph M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323375/ https://www.ncbi.nlm.nih.gov/pubmed/35884558 http://dx.doi.org/10.3390/cancers14143497

Ejemplares similares

Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021)

Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross‐disciplinary translational hypothesis
por: Norris, Joseph M., et al.
Publicado: (2020)

Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy
por: Morka, Naomi, et al.
Publicado: (2021)

Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta-analysis
por: Satish, Pranav, et al.
Publicado: (2022)

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
por: Norris, Joseph M., et al.
Publicado: (2020)

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis
por: Norris, Joseph M, et al.
Publicado: (2020)

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol
por: Norris, Joseph M., et al.
Publicado: (2020)

Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis
por: Norris, Joseph M, et al.
Publicado: (2020)

Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis
por: Thomas, Maya, et al.
Publicado: (2023)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Discrepancy between Multiparametric Magnetic Resonance Imaging and (68)Ga Prostate-Specific Membrane Antigen Positron Emission Tomography: A Simultaneous Acquired Positron Emission Tomography-Magnetic Resonance Imaging Case
por: Moolan, Naveen Jose, et al.
Publicado: (2021)

Multiparametric [(11)C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer
por: Polanec, Stephan H., et al.
Publicado: (2017)

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
por: Norris, Joseph M., et al.
Publicado: (2020)

Editorial Comment: Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography
por: Teles, Saulo Borborema, et al.
Publicado: (2023)

Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml
por: Soni, Brijesh Kumar, et al.
Publicado: (2021)

Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography
por: Jadvar, Hossein
Publicado: (2015)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
por: Abd-Alazeez, Mohamed, et al.
Publicado: (2014)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020)

New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging
por: Manfredi, Celeste, et al.
Publicado: (2021)

(68)Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review
por: Oliveira, Jose M., et al.
Publicado: (2017)

Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic
por: Morka, Naomi, et al.
Publicado: (2021)

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

Radical Prostatectomy without Prior Biopsy in Patients with High Suspicion of Prostate Cancer Based on Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography: A Prospective Cohort Study
por: Chaloupka, Michael, et al.
Publicado: (2023)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
por: Natarajan, Aravintho, et al.
Publicado: (2019)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review
por: Theodoropoulos, Athanasios S, et al.
Publicado: (2020)

Comparison of (68)Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis
por: Ling, Sui Wai, et al.
Publicado: (2021)

“Textural analysis of multiparametric MRI detects transition zone prostate cancer”
por: Sidhu, Harbir S., et al.
Publicado: (2016)

Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
por: Singh, Harmandeep
Publicado: (2020)

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of a Patient with Squamous Cell Carcinoma of Prostate
por: Kara Gedik, Gonca, et al.
Publicado: (2014)

Positron emission tomography and perfusion weighted imaging in the detection of brain tumors recurrence: A meta-analysis
por: Daqqaq, Tareef S., et al.
Publicado: (2022)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
por: Hrinivich, William T., et al.
Publicado: (2019)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Upcoming Role of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Detecting Occult Metastases in Prostate Cancer
por: Gupta, Parul, et al.
Publicado: (2019)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
por: Gupta, Manoj, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qh4kt2lb22m6fhe2r4rhatv1pu